Krishnasamy Panneerselvam

Title: Krishnasamy Panneerselvam: Innovator in Glycopegylated Factor IX Conjugates

Introduction

Krishnasamy Panneerselvam is a notable inventor based in Poway, CA (US). He has made significant contributions to the field of biochemistry, particularly in the development of glycopegylated factor IX conjugates. His innovative work has implications for treating various disease conditions.

Latest Patents

Panneerselvam holds a patent for "Glycopegylated factor IX." This patent discloses conjugates between Factor IX and PEG moieties, which are linked via a glycosyl linking group. The conjugates are formed from glycosylated peptides through the action of a glycosyltransferase. This enzyme ligates a modified sugar moiety onto a glycosyl residue on the peptide. The patent also provides methods for preparing these conjugates, as well as pharmaceutical formulations that include them.

Career Highlights

Throughout his career, Panneerselvam has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Novo Nordisk A/S and Halozyme, Inc. His experience in these organizations has contributed to his expertise in the development of innovative therapeutic solutions.

Collaborations

Some of his notable coworkers include Shawn DeFrees and Robert J Bayer. Their collaboration has likely fostered an environment of innovation and creativity in their respective projects.

Conclusion

Krishnasamy Panneerselvam is a distinguished inventor whose work on glycopegylated factor IX conjugates has the potential to advance therapeutic options for various diseases. His contributions to the field of biochemistry are noteworthy and reflect his commitment to innovation.